What is Kymera Therapeutics's EV / sales?

Kymera Therapeutics (KYMR) reported EV / sales of 130.9× in Q1 2026.

How has Kymera Therapeutics's EV / sales changed year-over-year?

Kymera Therapeutics's EV / sales increased by 334.1% year-over-year, from 30.2× to 130.9×.

What is the long-term trend for Kymera Therapeutics's EV / sales?

Over 5 years (2020 to 2025), Kymera Therapeutics's EV / sales has grown at a 13.4% compound annual growth rate (CAGR), from 81× to 151.8×.

What does EV / sales mean?

Enterprise value at the quarter end divided by trailing-twelve-month revenue. A capital-structure-neutral revenue multiple, useful when earnings are negative.

Kymera Therapeutics KYMR EV / sales

EV / sales at other companies

PfizerPFE

3.5×+0.3×

Johnson & JohnsonJNJ

6.5×+1.8×

Regeneron PharmaceuticalsREGN

5.5×+0.6×

ImmunityBio, Inc.IBRX

57.9×-33.2×

Krystal Biotech, Inc.KRYS

16.9×+2.2×

Protagonist TherapeuticsPTGX

88.3×+74.7×

Other financials

Income statement

See full

Revenue$34.4M+55.5%

Operating income-$84.2M-13.1%

Net income-$69.2M-5.6%

EPS (diluted)-$0.71+13.4%

Balance sheet

See full

Cash & equivalents$144.1M+60.2%

Total debt$82.2M-6.5%

Total equity$1.5B+95.8%

Total assets$1.7B+81.7%

Cash flow

See full

Operating cash flow-$88.8M-12.2%

CapEx$434.0K-7.1%

Free cash flow-$89.3M-12.1%

Valuation

See full

Market cap$7.44B+283%

Enterprise value$7.38B+280%

P/S144.5×+111×

Profitability

See full

Operating margin-697.7%+635pp

Net margin-612%+602pp

FCF margin-474%+92.4pp

Returns & leverage

See full

Return on equity-27.1%-3.7pp

Debt / equity0.1×-0.1×

Current ratio10.8×+2.3×

Where this comes from

Calculated from Kymera Therapeutics’s reported figures.

enterprise value/total revenue=130.9×

Based on the most recent quarter.

The official record: Kymera Therapeutics’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Kymera Therapeutics's ev / sales.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Kymera Therapeutics's EV / sales?: Kymera Therapeutics (KYMR) reported EV / sales of 130.9× in Q1 2026.
How has Kymera Therapeutics's EV / sales changed year-over-year?: Kymera Therapeutics's EV / sales increased by 334.1% year-over-year, from 30.2× to 130.9×.
What is the long-term trend for Kymera Therapeutics's EV / sales?: Over 5 years (2020 to 2025), Kymera Therapeutics's EV / sales has grown at a 13.4% compound annual growth rate (CAGR), from 81× to 151.8×.
What does EV / sales mean?: Enterprise value at the quarter end divided by trailing-twelve-month revenue. A capital-structure-neutral revenue multiple, useful when earnings are negative.